Jim Cramer’s Charitable Trust purchased 85 shares of Kimberly-Clark at approximately $97 per share, bringing its total position to 600 shares. This addition comes as Kimberly-Clark moves closer to completing its acquisition of Kenvue, valued at over $40 billion. The European Commission approved the deal conditional on Kimberly-Clark divesting its tampon and feminine hygiene brands in the region, and Kenvue bondholders have already consented to the note terms change. The combined entity will become the second-largest consumer health and wellness company by revenue, bringing together brands such as Huggies, Kleenex, Band-Aid and Tylenol. Despite a disappointing third quarter due to headwinds in China, rising freight costs and inventory de-stocking in the professional channel, management expects the deal to close this quarter.
Source: Read the original article
